(Q77050795)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10155266%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

title

The costs of treating febrile neutropenia in patients with malignant blood disorders (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10155266%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

author name string

B Leese

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10155266%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

R Collin

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10155266%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

D J Clark

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10155266%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

publication date

1 September 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10155266%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10155266%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10155266%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10155266%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

page(s)

233-239

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10155266%20AND%20SRC:MED&resulttype=core&format=json

Recombinant granulocyte colony-stimulating factor (rG-CSF). A review of its pharmacological properties and prospective role in neutropenic conditions

2 December 2019

cites work

1 reference

12 December 2020

The costs of treating febrile neutropenia in six U.K. Hospitals

1 reference

12 December 2020

Cost considerations in therapy with myeloid growth factors.

1 reference

12 December 2020

Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung Cancer

1 reference

12 December 2020

Recombinant granulocyte colony-stimulating factor (rG-CSF): pharmacoeconomic considerations in chemotherapy-induced neutropenia

1 reference

12 December 2020

Current issues in the antibiotic primary management of the febrile neutropenic cancer patient: a perspective from the National Cancer Institute

1 reference

12 December 2020